Dark Forest Capital Management LP Arcutis Biotherapeutics, Inc. Transaction History
Dark Forest Capital Management LP
- $718 Million
- Q3 2024
A detailed history of Dark Forest Capital Management LP transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Dark Forest Capital Management LP holds 16,817 shares of ARQT stock, worth $249,900. This represents 0.02% of its overall portfolio holdings.
Number of Shares
16,817
Previous 27,612
39.1%
Holding current value
$249,900
Previous $256,000
39.06%
% of portfolio
0.02%
Previous 0.05%
Shares
4 transactions
Others Institutions Holding ARQT
# of Institutions
197Shares Held
129MCall Options Held
738KPut Options Held
82K-
Jennison Associates LLC11.7MShares$173 Million0.07% of portfolio
-
Rubric Capital Management LP New York, NY11MShares$163 Million2.84% of portfolio
-
Suvretta Capital Management, LLC New York, NY10.7MShares$159 Million3.92% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.79MShares$131 Million4.4% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$128 Million0.0% of portfolio
About Arcutis Biotherapeutics, Inc.
- Ticker ARQT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,187,500
- Market Cap $894M
- Description
- Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...